Correlation of age-of-onset of Atopic Dermatitis with Filaggrin loss-of-function variant status

被引:0
作者
S. P. Smieszek
S. Welsh
C. Xiao
J. Wang
C. Polymeropoulos
G. Birznieks
M. H. Polymeropoulos
机构
[1] Vanda Pharmaceuticals Inc.,
来源
Scientific Reports | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The genetic background of Atopic Dermatitis (AD) with chronic pruritus is complex. Filaggrin (FLG) is an essential gene in the epidermal barrier formation s. Loss-of-function (LOF) variants in FLG associated with skin barrier dysfunction constitute the most well-known genetic risk factor for AD. In this study, we focused on the frequency and effect of FLG loss-of-function variants in association with self-reported age-of-onset of AD. The dataset consisted of 386 whole-genome sequencing (WGS) samples. We observe a significant association between FLG LOF status and age-of-onset, with earlier age of onset of AD observed in the FLG LOF carrier group (p-value 0.0003, Wilcoxon two-sample test). We first tested this on the two most prevalent FLG variants. Interestingly, the effect is even stronger when considering all detected FLG LOF variants. Having two or more FLG LOF variants associates with the onset of AD at 2 years of age. In this study, we have shown enrichment of rare variants in the EDC region in cases compared with controls. Age-of-onset analysis shows not only the effect of the FLG and likely EDC variants in terms of the heightened risk of AD, but foremost enables to predict early-onset, lending further credence to the penetrance and causative effect of the identified variants. Understanding the genetic background and risk of early-onset is suggestive of skin barrier dysfunction etiology of AD with chronic pruritus
引用
收藏
相关论文
共 51 条
  • [1] Chiesa Fuxench ZC(2019)Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population J. Invest. Dermatol. 139 583-590
  • [2] Elmose C(2015)Twin Studies of Atopic Dermatitis: Interpretations and Applications in the Filaggrin Era J. Allergy 2015 902359-22
  • [3] Thomsen SF(1992)Genetic risk for asthma, allergic rhinitis, and atopic dermatitis Arch. Dis. Child. 67 1018-94
  • [4] Dold S(2010)An update on the genetics of atopic dermatitis: Scratching the surface in 2009 Journal of Allergy and Clinical Immunology 125 16-29.e11-379
  • [5] Wjst M(2009)Filaggrin in the frontline: role in skin barrier function and disease J. Cell Sci. 122 1285-200
  • [6] von Mutius E(2014)Skin Barrier and Immune Dysregulation in Atopic Dermatitis: An Evolving Story with Important Clinical Implications J. Allergy Clin. Immunol. Pract. 2 371-804
  • [7] Reitmeir P(2016)Genetic and epigenetic studies of atopic dermatitis Allergy, Asthma Clin. Immunol. 12 52-342
  • [8] Stiepel E(2005)Stratum Corneum Defensive Functions: An Integrated View J. Invest. Dermatol. 125 183-654
  • [9] Barnes Kathleen C.(2018)Concentration of filaggrin monomers, its metabolites and corneocyte surface texture in individuals with a history of atopic dermatitis and controls J. Eur. Acad. Dermatology Venereol. 32 796-871
  • [10] Sandilands A(2006)Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris Nat. Genet. 38 337-1202